ClinicalTrials.Veeva

Menu

Intraoperative Ketamine and Magnesium Therapy for Control of Postoperative Pain After a Liposuction and Lipoabdominoplasty (KEMPLA)

U

University of Chile

Status

Completed

Conditions

Pain, Postoperative

Treatments

Drug: Ketamine + magnesium
Drug: Saline
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT02450214
OAIC N 722/15

Details and patient eligibility

About

Lipoabdominoplasty and liposuction are one of the most common plastic surgeries. The management of postoperative pain is complex. Non Steroidal Anti Inflammatory Drugs (NSAIDs) are insufficient, while opioids are avoided by their adverse effects and regional techniques are hampered by a premature discharge. In this context, the investigators seek an intraoperative multimodal analgesic technique blocking NMDA receptors with ketamine plus magnesium to significantly decrease postoperative pain.

Enrollment

63 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female and male
  • 18 years or older
  • Liposuction and lipoabdominoplasty
  • ASA 1 and 2
  • BMI 21-28 Kg/m2
  • Full secondary education

Exclusion criteria

  • Patients with surgeries added to the main proceedings
  • Scheduled to tuck in Flor de Lis or Body Lift
  • History of use of analgesic drugs 48 hours before surgery
  • Peripheral central neurological diseases
  • Known allergy will be excluded to medication in use in this study (ketamine, magnesium, clindamycin and penicillin or other)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

63 participants in 3 patient groups

Control group (C)
Sham Comparator group
Description:
50 mL syringe with saline, plus 1 flask of 100 mL saline (Saline)
Treatment:
Drug: Saline
Ketamine group (K)
Experimental group
Description:
50 mL syringe with ketamine (50mg / 50ml), plus 1 flask of 100 mL saline (Ketamine)
Treatment:
Drug: Ketamine
Magnesium + ketamine group (MGK)
Experimental group
Description:
50mL syringe with ketamine (50mg / 50ml), plus a flask of 100ml of saline with 5 g of magnesium sulfate (Ketamine + magnesium)
Treatment:
Drug: Ketamine + magnesium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems